Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.
4 results about "Erythrina" patented technology
Filter
Efficacy Topic
Property
Owner
Technical Advancement
Application Domain
Technology Topic
Technology Field Word
Patent Country/Region
Patent Type
Patent Status
Application Year
Inventor
Erythrina /ˌɛrɪˈθraɪnə/ is a genus of flowering plants in the pea family, Fabaceae. It contains about 130 species, which are distributed in tropical and subtropical regions worldwide. They are trees, with the larger sp[ecies growing up to 30 m (98 ft) in height. The generic name is derived from the Greek word ερυθρóς (erythros), meaning "red", referring to the flower color of certain species.
This invention provides the application of Erythrinabark in the preparation of drugs for the prevention and / or treatment of infectious coryza in chickens. The active ingredient of this drug can be composed solely of Erythrinabark, making the formulation easy and convenient to implement. It can be used as a substitute for antibiotics during the egg-laying period of chickens, with no drug residue requirements, reducing the economic loss of discarded eggs after the use of antibiotics in laying hens. It has a high cure rate for infectious coryza, is safe and has no toxic side effects, and is easy to use.
The invention relates to a traditional Chinese medicine composition for treating gout and a pill preparation thereof, the composition takes rhizoma smilacis glabrae and corn stigma as monarch drugs, Chinese actinidia root, fructus polygoni orientalis and the like as ministerial drugs, and erythrinabark, fructus viticis and the like as adjuvant drugs, and the synergistic effect of reducing uric acid and resisting inflammation is realized through scientific compatibility. Experiments show that the preparation can significantly reduce the blood uric acid level of gout model animals, inhibit anklejoint swelling and improve the symptoms of patients through clinical verification, and the safety is superior to that of a traditional western medicine scheme. The technical problems that an existing traditional Chinese medicine preparation is single in target spot and obvious in side effect are solved, and a new solution is provided for gout treatment.